A Phase 1b/2a study of the safety and efficacy of MAR001 in patients with metabolic dysfunction (NCT05896254)

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo